awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36888347-16388C3E-07A5-4DA1-8EF0-E42CA48DA9C7
Q36888347-16388C3E-07A5-4DA1-8EF0-E42CA48DA9C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36888347-16388C3E-07A5-4DA1-8EF0-E42CA48DA9C7
The PPARγ agonist efatutazone increases the spectrum of well-differentiated mammary cancer subtypes initiated by loss of full-length BRCA1 in association with TP53 haploinsufficiency.
P2860
Q36888347-16388C3E-07A5-4DA1-8EF0-E42CA48DA9C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36888347-16388C3E-07A5-4DA1-8EF0-E42CA48DA9C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
29393027e0aff175928ee2b24acd2d9f711cc808
P2860
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.